---
category: news
title: "It’s All in the Model, When It Comes to Pricing Gilead’s Covid-19 Drug"
excerpt: "A research group that recommends drug pricing has pegged remdesivir’s price at $4,500 or $10 for a course of treatment. The source of that disparity: Whethe you’re looking at production costs or cost-effectiveness."
publishedDateTime: 2020-05-08T22:29:00Z
webUrl: "https://www.barrons.com/articles/its-all-in-the-model-when-it-comes-to-pricing-gileads-covid-19-drug-51588980565"
ampWebUrl: "https://www.barrons.com/amp/articles/its-all-in-the-model-when-it-comes-to-pricing-gileads-covid-19-drug-51588980565"
cdnAmpWebUrl: "https://www-barrons-com.cdn.ampproject.org/c/s/www.barrons.com/amp/articles/its-all-in-the-model-when-it-comes-to-pricing-gileads-covid-19-drug-51588980565"
type: article
quality: 75
heat: 75
published: false

provider:
  name: Barron's
  domain: barrons.com

topics:
  - Treatment
  - Coronavirus

images:
  - url: "https://images.barrons.com/im-185267/social"
    width: 1280
    height: 640
    title: "It’s All in the Model, When It Comes to Pricing Gilead’s Covid-19 Drug"

secured: "xGKo9irr5V2NhsWkX0UAK+IGlkgzUu4YOVAH14QpAzqQXwpIrJkFH9/0UoPOGtrzTJiQjIEoeEyt/mg3N+4L/B7Cqjsb65k1A+LkfDKJZoYResnTF1LdKMuGVVCApyhvFzb44qZ5rhcmZvlIaKGyRsvNCNjCABRoYJV8X3iapJUTTmGs4HRyeZ2uXQseod9kTe9a8MwpGWLvzPO4vOlMeWW87g0dSR/qcJgLj1PH3VHWod9kVhqGnw2PUhiGyHNUsovgI1m+Ho+RPuwGSrIvGlYJU5RsJBQSZrnBonx7MKgywKNiPjqUVzS+27WUMUqD;k7fJ67HFmJ23gtCIncgE5Q=="
---

